AVH 8.00% $2.70 avita medical inc.

RE: BARDA Contract to Advance Development of RECELL® System in Soft Tissue Reconstruction, page-8

  1. 223 Posts.
    lightbulb Created with Sketch. 8
    INDICATIONS FOR USE: The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds. The RECELL device is used by an appropriately-licensed healthcare professional at the patient’s point of care to prepare autologous RES® Regenerative Epidermal Suspension for direct application to acute partial-thickness thermal burn wounds in patients 18 years of age and older or application in combination with meshed autografting for acute full-thickness thermal burn wounds in pediatric and adult patients.
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
(20min delay)
Last
$2.70
Change
0.200(8.00%)
Mkt cap ! $187.0M
Open High Low Value Volume
$2.51 $2.81 $2.51 $2.547M 942.1K

Buyers (Bids)

No. Vol. Price($)
1 36 $2.69
 

Sellers (Offers)

Price($) Vol. No.
$2.75 100 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.